Document is current
Any future updates will be listed below
-
Authors
Los, Jonathan https://orcid.org/0000-0002-6731-0965
Mensink, Frans B.
Bulut, Özlem
Hol, Ilse H.
Cetinyurek-Yavuz, Aysun
Riksen, Niels P.
El Messaoudi, Saloua
Cornel, Jan H.
van Geuns, Robert-Jan M. https://orcid.org/0000-0003-2943-5932
-
Funding
Funding for this research was provided by:
Amgen Nederland
InfraRedx
Health~Holland
- License Information
-
More Information
Article History
Received: 26 January 2026
Accepted: 8 June 2026
First Online: 29 June 2026
Declarations
:
: Niels P. Riksen is financially supported by a consortium grant of the Dutch Heart Foundation (AtheroNeth; 01–001-2024–0601) and a Vici grant of the Netherlands Organization for Health Research and Development (ZonMw; 09150182410037).Robert-Jan M. van Geuns reports consulting and speaker fees from Abbott Vascular and Astra Zeneca, and received institutional research grants from Amgen, InfraRedx, Astra Zeneca, and Sanofi.The remaining authors report no relationships that could be construed as a conflict of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration. Informed consent was obtained from all patients for being included in the study.
